Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 106

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 106
---
 of Alcon equal to (a) the total number of shares subject to such
STAAR RSU Award immediately prior to the Effective Time, multiplied by (b) the RSU Exchange Ratio, and otherwise subject to the same terms and conditions as apply to such STAAR RSU Award as of immediately prior to the Effective Time
(including that the vesting will be accelerated pro rata upon a termination within 24 months following the Effective Time without cause or, for employees at the Vice President level or above, for good reason).

STAAR PSU Awards. At the Effective Time, each STAAR PSU Award (whether or not then vested) will be cancelled and the holder will be
entitled to receive a cash payment equal to the product of (i) the Merger Consideration and (ii) the total number of shares subject to such STAAR PSU Award immediately prior to the Effective Time, with performance deemed achieved at 160%
of the target level.

For an estimate of the value of unvested equity awards held by STAAR’s named executive officers that would
vest assuming that the Merger occurs on August 27, 2025, see “—Quantification of Payments and Benefits to STAAR’s Named Executive Officers” below. We estimate that the aggregate value of unvested equity awards
held by all non-employee directors of STAAR that would vest assuming that the Merger occurs on August 27, 2025 is $2,553,676, calculated based on the Merger Consideration of $28.00 per share.

Employment Agreement

STAAR is
party to an employment agreement with Mr. Farrell. Under the employment agreement, in the event of a termination without cause within 12 months following a change in control or for good reason within 18 months following a change in control,
Mr. Farrell would be entitled to the following severance payments and benefits: (a) 24 months of base salary; (b) an amount equal to his bonus, if any, for the year prior to termination; (c) an amount equal to his target bonus
for the year of termination; (c) reimbursement of group health coverage premiums for 24 months; and (d) accelerated vesting of all outstanding equity or other incentive compensation awards. The foregoing severance payments and benefits are
generally subject to Mr. Farrell’s execution and nonrevocation of a release of claims.

Change in Control Agreements

STAAR is party to a change in control agreement with each of its